Seattle Genetics Inc
Change company Symbol lookup
Select an option...
SGEN Seattle Genetics Inc
WEC WEC Energy Group Inc
PFE Pfizer Inc
T AT&T Inc
BFC Bank First Corp
RIGMF Ridgestone Mining Inc
BAC Bank of America Corp
WFC Wells Fargo & Co
ASB Associated Banc-Corp
WSBF Waterstone Financial Inc
Go

Health Care : Biotechnology | Large Cap Growth
Company profile

Seattle Genetics, Inc. is a biotechnology company focused on the development and commercialization of therapies for the treatment of cancer. The Company is engaged in the development and sale of pharmaceutical products on its own behalf or in collaboration with others. The Company's marketed product ADCETRIS, or brentuximab vedotin, is an antibody-drug conjugate (ADC). In addition to ADCETRIS, the Company's pipeline includes other clinical-stage ADC programs, such as ASG-22ME, SGN-LIV1A, SGN-CD19A, SGN-CD19B, SGN-CD123A, SGN-352A, and ASG-15ME, as well as two immuno-oncology agents, SEA-CD40, which is based on its sugar-engineered antibody (SEA) technology, and SGN-2FF, which is a small molecule. It also has multiple preclinical and research-stage programs that employ its technologies, including SGN-CD48A and a preclinical ADC. ADCETRIS is an ADC comprising an anti-CD30 monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent.

Closing Price
$169.03
Day's Change
1.51 (0.90%)
Bid
--
Ask
--
B/A Size
--
Day's High
170.36
Day's Low
166.02
Volume
(Light)
Volume:
782,908

10-day average volume:
1,200,706
782,908
  • Prev Close
    167.52
  • Today's Open
    167.75
  • Day's Range
    166.02-170.36
  • Avg Vol (10-day)
    1.2M
  • Last (time)
    4:00p ET 07/02/20
  • Last (size)
    100
  • 52-Wk Range
    63.02 - 175.64
    LowHigh
  • (07/16/19 - 06/23/20)
    3.76%
  • 48.5%
  • Market Cap
    29.3B
  • Shares Outstanding
    173.1M
  • -1.86
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.5
  • 100.86
  • (% of float 06/15/20)
    2.68

Latest News

July 01, 2020
7:30 am ET
Globe Newswire
6:24 am ET
MarketWatch
June 29, 2020
4:30 pm ET
BusinessWire
June 20, 2020
8:45 pm ET
MarketWatch
June 18, 2020
8:00 am ET
BusinessWire
June 03, 2020
8:00 am ET
BusinessWire
May 29, 2020
8:00 am ET
BusinessWire
May 19, 2020
1:03 pm ET
MarketWatch
May 18, 2020
8:00 am ET
BusinessWire
May 14, 2020
8:00 am ET
BusinessWire
May 13, 2020
5:12 pm ET
BusinessWire
May 12, 2020
8:00 am ET
BusinessWire
May 09, 2020
2:19 pm ET
MarketWatch
May 05, 2020
8:00 am ET
BusinessWire
April 30, 2020
4:02 pm ET
BusinessWire
April 24, 2020
8:00 am ET
BusinessWire
April 22, 2020
2:20 pm ET
MarketWatch
April 17, 2020
2:46 pm ET
MarketWatch
2:27 pm ET
BusinessWire
April 15, 2020
11:46 am ET
MarketWatch
April 13, 2020
8:00 am ET
BusinessWire
April 08, 2020
8:00 am ET
BusinessWire
April 03, 2020
5:24 pm ET
MarketWatch
March 27, 2020
6:43 am ET
MarketWatch
March 05, 2020
6:36 am ET
MarketWatch
January 28, 2020
9:17 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.